CardioNext® is a genetic test for the analysis of polymorphisms associated with an increased risk of onset of cardiovascular diseases. The aim of the test is to determine individual risk profiles for personalized treatments and early prevention of these diseases.
The onset of cardiovascular diseases is induced by various factors such as diet and lifestyle and genetics, which play a very important role.
Being aware of the genetic predispositions for the development of these diseases allows to undertake preventive and corrective measures in order to anticipate, and in some cases avoid, the clinical manifestation.
The test is based on the analysis of 50 polymorphisms, located on 38 genes using Next Generation Sequencing (NGS) techniques.